Oramed Pharmaceuticals Inc. (ORMP)
Market Closed
30 Jul, 15:25
TASE 
1,241. 00
ILA -27
-2.1293%
- Market Cap
16.21 P/E Ratio
- Div Yield
1,998 Volume
-0.31 Eps
1,268 ILA
Previous Close Want to track ORMP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oramed Pharmaceuticals Inc. (ORMP) Statistics
Valuation metrics
Market Cap -
Enterprise value 152.49M
Trailing P/E (ttm) 1.52
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.69
Enterprise Value/Revenue -
Enterprise Value/EBITDA 1.93
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.27K
Average volume (90 days) 8.3K
Price summary
52-Week low 680
52-Week high 1,499
Beta -
50-Day moving average 1,235.2
200-Day moving average 1,134.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.25
Trailing annual dividend yield 0.062%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 26 Jan 2026
Ex-Dividend Date 16 Jan 2026
Last split factor 1:12
Last split Date 23 Jan 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.41%
Return on equity 0.55%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.61
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 6.45%
Book value per share (mrq) 5.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
